Evidence map›Paper›PMID 18676179›Full record

ReviewTrends in immunology2008

Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts.

Ivona Pandrea, Donald L Sodora, Guido Silvestri, Cristian Apetrei

Open access · greenAbstract readReview
In one paragraph

Review in Trends in immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 176 citations in OpenAlex.

  1. The Hitchhiker Guide to CD4Frontiers in immunology · 2021
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Host ZAP activity correlates with the levels of CpG suppression in primate lentiviruses.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. CD32Frontiers in immunology · 2021
    Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ivona PandreaComparative Pathology, Tulane National Primate Research Center, Covington, LA 70433, USA.
Donald L Sodora
Guido Silvestri
Cristian Apetrei
Tulane University · USCenter for Infectious Disease Research · USUniversity of Pennsylvania · US

Funding

ZETA CHAIN OF T CELL RECEPTOR INTERACTS W/ NEF OF SIV &HIV2P51RR000168 · NCRR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WESTMORELAND, SUSAN V. · 1985 to 2011
$139.3M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
TNF AND MCP-1 IN RETROVIRUS-INDUCED BRAIN DISEASEP20RR020159 · NCRR · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI KOUSOULAS, KONSTANTIN G · 2004 to 2011
$16.1M
Studies of Natural SIV Infection of Sooty MangabeysR01AI066998 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SILVESTRI, GUIDO · 2006 to 2010
$3.5M
Pathogenesis of SIV in African green monkeysR01AI064066 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2005 to 2010
$2.8M
VIROLOGY AND IMMUNOLOGY OF ACUTE HIV1 INFECTIONR01AI035522 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI PETERSON, DOLORES MURL · 1994 to 2006
$2.7M
Pathogenesis of New SIVsm Lineages in Rhesus MacaquesR01AI065325 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN · 2006 to 2009
$2.6M
MOUSE MODELS OF CANCER, BONE DISEASE, AND LACTATIONK26RR000168 · NCRR · OHIO STATE UNIVERSITY · PI ROSOL, THOMAS J · 2000 to 2004
$547k
Viral Cytopathicity in CD4-Low SIV Passaged MangabeysR21AI060451 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI PETERSON, DOLORES MURL · 2005 to 2006
$530k
T regulatory cells in Rhesus Macaques and African green monkeysR21AI069935 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI PANDREA, IVONA · 2006 to 2007
$445k
NCRR NIH HHS K26 RR000168NCRR NIH HHS P20 RR020159NCRR NIH HHS P51 RR000165NCRR NIH HHS P51 RR000168NCRR NIH HHS RR-00165NCRR NIH HHS RR-00168NIAID NIH HHS R01 AI035522NIAID NIH HHS R01 AI064066NIAID NIH HHS R01 AI065325NIAID NIH HHS R01 AI066998NIAID NIH HHS R21 AI060451NIAID NIH HHS R21 AI069935NIAID NIH HHS R21AI069935
6 · The paper itself

Abstract

Identifying distinctions between pathogenic HIV and simian immunodeficiency virus (SIV) infections and nonprogressive SIV in natural African primate hosts might provide key insights into HIV pathogenesis. Similar to pathogenic HIV infection in humans, natural SIV infections result in high viral replication and massive acute depletion of mucosal CD4(+) T cells. A key distinction of natural SIV infections is a rapidly developing anti-inflammatory milieu that prevents chronic activation, apoptosis and proliferation of T cells and preserves the function of other immune cell subsets, thus contributing to the integrity of the mucosal barrier and the lack of microbial translocation from the gut to the peritoneum. Immunologic features observed during natural SIV infections suggest approaches for designing new strategies for producing novel second-generation vaccines and therapeutic approaches to inhibit disease progression in HIV-infected humans.

Indexed as

AnimalsCD4-Positive T-LymphocytesHIV InfectionsHumansImmunityModels, ImmunologicalPrimatesSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency Virus

Identifiers

PMID18676179
PMCPMC2840226
OpenAlexW2055421491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.